GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion
GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion is indicated for use in the treatment of portal hypertension and its complications such as: variceal bleeding refractory to, or intolerant of, conventional therapies, inaccessible varices, gastropathy, refractory ascites, and/or hepatic hydrothorax.
Products presented on this platform may not be available in all markets.
Please refer to our website www.goremedical.com for more information.
Why to use it
For your patients with portal hypertension, the GORE® VIATORR® TIPS Endoprosthesis maintains significantly increased patency compared to bare metal stent alternatives.
Highly effective in lowering portal pressure gradients in patients with refractory ascites and variceal bleeding, the GORE® VIATORR® TIPS Endoprosthesis effectively treats patients over a longer period.
The GORE® VIATORR® TIPS Endoprosthesis is an innovative solution for TIPS in both de novo and revision procedures.
Instructions for use
The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion is identical to the GORE® VIATORR® TIPS Endoprosthesis with the added feature of controlled expansion. The controlled expansion feature is provided by a balloon expandable sleeve, identified as the controlled expansion sleeve, on the lined region of the endoprosthesis. This feature allows balloon adjustment of the endoprosthesis diameter and maintains the selected diameter.
Lasting Diameter Control*
– Control the diameter to reach a targeted portal pressure gradient
– Size and set the diameter to stay*;
Select from a range of diameters during implantation**;
Count on advanced performance that combines a legacy of proven patency*** with diameter control.
* Based on benchtop data on file. Less than 0.25 mm increase in diameter (diameter expansion) demonstrated by a simulated 10 year period at physiologic portal pressures.
** Labeled diameter range is between 8–10 mm.
*** Based on GORE® VIATORR® TIPS Endoprosthesis: Bureau C, Pagan JCG, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long term results of a randomized multicentre study. Liver International 2007;27(6):742-747.